NCT05843877 2026-01-30
XandTX
Technische Universität Dresden
Phase 3 Recruiting
Clinical Trials
31 trialsNCT06132087 2025-11-25
PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy
University of Southern California
Phase NA Active not recruiting
NCT07159672 2025-09-08
Cohort Study on Nutritional, Metabolic, and Volumetric Assessment After Pancreaticoduodenectomy
University of Sao Paulo
Completed
NCT02892305 2025-08-06
Hepatic Resection for Metastatic Pancreatic Cancer
Duke University
Active not recruiting
NCT02517268 2025-04-30
WARP
Thomas Jefferson University
Phase NA Completed
NCT05462496 2024-10-15
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Recruiting
NCT06641947 2024-10-15
D
First Affiliated Hospital of Chongqing Medical University
Completed
NCT05017207 2024-05-17
Clinically Relevant Pancreatic Fistula After Pancreaticoduodenectomy
University of Medicine and Pharmacy at Ho Chi Minh City
Completed
NCT04985071 2024-05-13
PF
University of Medicine and Pharmacy at Ho Chi Minh City
Completed
NCT06206382 2024-01-16
Surgical Results of Resection of Locally Advanced Pancreatic Cancer
Assiut University
Unknown
NCT04596865 2023-11-18
Recurrence After Whipple's (RAW) Study
University Hospital Plymouth NHS Trust
Completed
NCT02243358 2023-10-27
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Henry Ford Health System
Phase 2 Completed
NCT04007640 2022-07-08
PAIR-PANCREAS
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT02787187 2021-11-23
Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?
Ruijin Hospital
Phase NA Completed
NCT05110573 2021-11-08
PSMLOPD
General Hospital Groeninge
Completed
NCT04724551 2021-05-28
NLR
Institut Paoli-Calmettes
Completed
NCT04847297 2021-04-19
PEAR
University of Pecs
Not yet recruiting
NCT04798560 2021-03-15
Identifing Risk Factors for Pancreaticojejunostomy Leakage Following Pancreaticoduodenectomy
University of Athens
Unknown
NCT03718650 2021-02-08
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Withdrawn
NCT04053998 2020-11-20
Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org
Royal Free Hospital NHS Foundation Trust
Completed
NCT02803814 2020-07-22
DUOPAN-EPAM
Fundación para la Investigación del Hospital ClÃnico de Valencia
Phase NA Completed
NCT01240304 2019-12-10
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
University of Arkansas
Phase 2 Terminated
NCT03659903 2018-09-06
Pancreaticoduodenectomy in Elderly Pancreatic Ductal Adenocarcinoma Patients
The First Affiliated Hospital of Dalian Medical University
Completed
NCT01989000 2018-06-27
MIPA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT03317886 2017-10-24
Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer
Wakayama Medical University
Phase 3 Unknown
NCT00766636 2016-05-19
Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02081131 2015-09-15
PLOT
GEM Hospital & Research Center
Phase NA Completed
NCT01941342 2014-01-14
Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy
Southwest Hospital, China
Phase 2 Unknown
NCT01278381 2011-01-17
Prognostic Score To Predict Major Complications After Pancreaticoduodenectomy
Università Vita-Salute San Raffaele
Completed
NCT00761241 2010-05-26
Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT
Benaroya Research Institute
Phase 2 Completed
NCT01059097 2010-01-29
Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy
Università Vita-Salute San Raffaele
Phase NA Completed